Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TicoVac in Healthy Japanese Participants
NCT04648241Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2021
- Primary completion
- Feb 2022
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Tick-borne encephalitis vaccine in tick-borne encephalitis (TBE), sponsored by Pfizer. Started Jan 2021; status: completed.
02
Drugs
Tick-borne encephalitis vaccine
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT04648241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04648241.